Recent advances in the field of obesity treatment have brought a novel drug known as ALLUVI Retatrutide. This compound is a {highlyeffective GLP-1 receptor agonist, designed to stimulate the effects of natural glucagon-like peptide-1. Retatrutide has shown impressive outcomes in clinical trials, exhibiting significant decreases in body weight and e